Delivery Order SPE2DR25D1017-SPE2DR26F9ECV
Award Date 1/30/26
Potential Completion Date 2/2/26
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,812.74 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pen injections on January 14, 2026. This is a firm fixed-price, non-set-aside delivery order with a completion date of January 15, 2026, to be performed at the awardee's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $5,719.35 to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injections. The contract represents a firm fixed price delivery order with a completion date of June 23, 2025, and was competitively awarded without a set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this order. This delivery order is...
- The Defense Logistics Agency awarded a $38,343.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 29, 2026, for the supply of Zepbound 7.5 mg/0.5 ml pens. The contract, which is not set-aside and was competitively awarded, has an ultimate completion date of January 30, 2026, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $8,777.80 to supply Zepbound 7.5 mg/0.5 ml pen injections, with an ultimate completion date of April 25, 2025. This firm fixed-price delivery order, awarded on April 24, 2025, represents a non-competitive set-aside purchase and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract is a child award under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,971.23 delivery order to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of Zepbound 7.5 mg/0.5 ml pen injections. This is a firm fixed-price, non-set-aside contract with a completion date of January 29, 2026, and performance location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to...
- The Defense Logistics Agency awarded a delivery order valued at $10,086.96 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 ml pen injections on January 8, 2026, with an ultimate completion date of January 9, 2026. This is a firm fixed-price contract with no set-aside designation, competitively awarded through open competition. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $37,543.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 15, 2026, for the supply of Zepbound 7.5 mg/0.5 ml pen injections. The contract, which concludes on January 16, 2026, was competitively awarded without set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,484.03 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $4,079.17 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections on January 21, 2026, with completion expected by January 22, 2026. This award represents a firm fixed-price transaction issued without set-aside designation, indicating competitive procurement. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent...
- The Defense Logistics Agency awarded a $35,191.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 15, 2026, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. The order was competitively awarded with no set-aside designation and is scheduled for completion by January 16, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical...